← Back to Clinical Trials
Recruiting NCT05154331

NCT05154331 Antenatal and Postnatal Care Research Collective - Household Survey (ARCH)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05154331
Status Recruiting
Phase
Sponsor University of North Carolina, Chapel Hill
Condition Maternal Health
Study Type OBSERVATIONAL
Enrollment 7,500 participants
Start Date 2022-03-29
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 1 Day
Max Age 49 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 7,500 participants in total. It began in 2022-03-29 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overarching goal of the ARCH Survey is to establish a prospective longitudinal pregnancy surveillance study in Lusaka, Zambia, to precisely characterize the pregnancy rate and outcomes of women of reproductive age prior to, during, and following pregnancy and to investigate the structural, sociodemographic, and clinical covariates that contribute to adverse outcomes in each reproductive epoch.

Eligibility Criteria

We will initially obtain verbal consent from the head of household (HoH), defined as an available adult (\> 18 years old) who is able to provide information about household composition for pre-screening purposes. We will then identify potentially eligible women of reproductive age within each household and invite them to complete study screening procedures. Women of reproductive age eligibility criteria Inclusion criteria: * Verbal consent obtained from head-of-household * 15-49 years of age and a member of household in the catchment area * Willing and able to provide written informed consent or assent with next-of-kin consent * Willing to undergo study procedures Exclusion criteria: Any other condition (social or medical) that, in the opinion of the study staff, would make participation unsafe or complicate data interpretation. Study staff may note physical, psychological, or social conditions not explicitly stated in the eligibility criteria that could make some women poor candidates for study participation.

Contact & Investigator

Central Contact

Mutale Sampa

✉ mutalesampa65@gmail.com

📞 +260977287091

Principal Investigator

Jeff Stringer

PRINCIPAL INVESTIGATOR

University of North Carolina, Chapel Hill

Frequently Asked Questions

Who can join the NCT05154331 clinical trial?

This trial is open to participants of all sexes, aged 1 Day or older, up to 49 Years, studying Maternal Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05154331 currently recruiting?

Yes, NCT05154331 is actively recruiting participants. Contact the research team at mutalesampa65@gmail.com for enrollment information.

Where is the NCT05154331 trial being conducted?

This trial is being conducted at Lusaka, Zambia.

Who is sponsoring the NCT05154331 clinical trial?

NCT05154331 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Jeff Stringer at University of North Carolina, Chapel Hill. The trial plans to enroll 7,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology